Picture of Arcadia Biosciences logo

RKDA Arcadia Biosciences Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
Basic MaterialsSpeculativeMicro CapValue Trap

Annual cashflow statement for Arcadia Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-28.9-6.03-16.1-15.6-14
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items12.1-12.4-6.521.041.91
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.592-12.4-4.260.118-3.51
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-17.2-30.2-25.9-14-15.3
Capital Expenditures-1.48-2.33-1.01-0.072-0.005
Purchase of Fixed Assets
Other Investing Cash Flow Items-6.8919.617.61.49-4.34
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-8.3717.316.61.42-4.34
Financing Cash Flow Items-0.7960.063-1.16-0.488-0.497
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities2220.621.94.525.51
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-3.587.6312.6-8.04-14.1